CPQCC hosted a webinar introducing the new Maternal Substance Exposure Data Collection Pilot Project.
Substance exposure among pregnant women is on the rise. Yet there is limited information on the treatment and outcomes of mothers and newborns that have been exposed. CPQCC is launching a maternal substance exposure data collection pilot project to improve understanding of this critical public health issue. By collecting data on all maternal substance exposures (including but not limited to opioids), we aim to improve healthcare for infants exposed in-utero by focusing on treatment and length of stay in the hospital. This data will be used to drive improvement in the care provided to exposed infants through a range of reports designed to help hospitals identify areas of high and low performance, monitor the effects of improvement interventions, and conduct research that advances the quality of care.
The Maternal Substance Exposure Data Collection Pilot is separate from the Mother & Baby Substance Exposure Initiative, which CPQCC is implementing in partnership with CMQCC and Health Management Associates in select counties across California. Hospitals that have been recruited to participate in the Mother & Baby Substance Exposure Initiative from the selected counties are strongly encouraged to also participate in the Maternal Substance Exposure Data Collection Pilot. Hospitals which are not part of the Mother & Baby Substance Exposure Initiative, including non-CPQCC member hospitals, are also strongly encouraged to join the data collection pilot.